Latest News

NIST Names VaxDesign Recipient of 3-Year, $1.49 Million Grant

Release Date: January 19, 2010

The U.S. Commerce Department's National Institute of Standards and Technology (NIST) awarded VaxDesign a 3-year grant with total funding of nearly $1.5 million for the development and validation of an in vitro human testbed for evaluation of therapeutic antibodies. With NIST receiving over 1,300 proposals for 27 grants awarded, VaxDesign is proud to be one of the grant recipients and excited about starting work on the project.

Read NIST's full press release on the NIST website.

News Archive

Release Date
January 19, 2010	NIST Names VaxDesign Recipient of 3-Year, $1.49 Million Grant
November 25, 2009	2009 Chemical and Biological Defense Conference Gives VaxDesign "Outstanding Collaboration" Award
June 2, 2009	VaxDesign is Now on Twitter
May 27, 2009	VaxDesign CEO Makes the Case for the MIMIC® System
May 12, 2009	MIMIC® System Helps U.S. Department of Defense Assess Plague Vaccine Candidate
January 29, 2009	VaxDesign's MIMIC® System receives 2009 Governor's New Product Award
September 19, 2008	VaxDesign to Discuss Alternative Methods to Animal Experimentation at Sanofi Pasteur in October
March 28, 2008	TIME Magazine Profiles VaxDesign’s MIMIC® Technology
October 27, 2007	TechJournal South Profiles VaxDesign
October 22, 2007	VaxDesign Receives Prestigious R&D 100 Award
October 1, 2007	BioWorld includes VaxDesign as one of the most innovative companies in biotechnology
September 19, 2007	VaxDesign Receives 2007 William C. Schwartz Industry Innovation Award
August 6, 2007	R&D Magazine Profiles VaxDesign
October 18, 2006	VaxDesign is Helping Central Florida "Break Out"
September 11, 2006	Orlando Sentinel Features VaxDesign
April 12, 2006	Newsweek/MSNBC Features VaxDesign
July 18, 2005	VaxDesign Signs Cooperative R&D Agreement with USAMRIID

Media Inquiries

VaxDesign and its staff have been featured in national publications and websites, such as TIME, Newsweek, MSNBC, Wired, as well as regional outlets, such as the Orlando Sentinel. Media inquiries for interview requests, photos, or technical clarification of any of our technologies should be directed to:

Michael D. Rivard
Vice President of Corporate Development
781-844-7252